Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
RXST
#2805
RxSight, Inc. Common Stock
7.4
8
-1.97%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.97%
Changement Mensuel
-18.96%
Evolution sur 6 mois
-14.32%
Changement Annuel
-73.75%
Clôture Précédente
7.6
3
Open
7.4
8
Bid
Ask
Low
7.4
8
High
7.4
8
Volume
65
Marchés
Actions des Marchés US
Soins de Santé
RXST
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
27.42 M
33.78 M
36.99 M
40.49 M
41.27 M
—
Valuation ratios
Enterprise value
284.09 M
419.82 M
1.35 B
1.38 B
410.05 M
2.24 B
Price to earnings ratio
-3.15
-5.3
-25.99
-48.42
-10.97
-76.02
Price to sales ratio
6.78
7.21
14.18
9.55
3.17
15.81
Price to cash flow ratio
-3.43
-6.01
-30.36
-78.85
27.44
-83.44
Price to book ratio
1.11
3.93
7.87
4.75
1.54
3.21
Enterprise value to EBITDA ratio
-5.82
-7.06
-29.25
-41.28
-9.12
-59.22
Profitability ratios
Return on assets %
0.25
0.44
0.27
0.09
0.12
0.13
Return on equity %
0.35
0.74
0.3
0.1
0.14
0.14
Return on invested capital %
884.61
956.41
613.43
318.63
334.43
257.29
Gross margin %
19.99
43.52
60.36
70.71
76.6
306.97
Operating margin %
233.64
129.21
56.23
26.34
35.84
144.7
EBITDA margin %
-216.05
-121.28
-51.65
-23.81
-33.43
-134.98
Net margin %
215.5
136.22
54.57
19.62
28.96
117.07
Liquidity ratios
Quick ratio
15.19
6.95
7.22
10.5
9.75
45.53
Current ratio
15.92
7.81
8.06
11.36
10.95
50.29
Inventory turnover
2.25
2.42
2.19
2.08
1.17
1.24
Asset turnover
0.12
0.29
0.54
0.56
0.43
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.21
0.27
0
—
—
—
Long term debt to total equity ratio
0.29
0.45
0
—
—
—
Per share metrics
Operating cash flow per share
3.28
2.13
1.21
0.44
0.38
0.38
EBIT per share
-3.87
-2.29
-1.45
-0.95
-1.18
-1.18
EBITDA per share
-3.58
-2.15
-1.34
-0.86
-1.1
-1.1
Total debt per share
—
—
—
—
—
—
Cash per share
11.69
3.82
3.69
6.1
5.58
22.38
Net current asset value per share
12.94
4.86
4.89
7.56
7.04
28.05
Tangible book value per share
10.15
3.25
4.65
7.24
6.75
27.2
Working capital per share
12.13
4.24
4.28
6.89
6.39
25.81
Book value per share
10.15
3.25
4.65
7.24
6.75
27.2
Nouvelles
Needham reiterates Buy on RxSight stock, keeps $13 target
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
Le BPA de Rxsight a dépassé les attentes de 0,32$, le CA a surpassé les prévisions
Rxsight earnings beat by $0.32, revenue topped estimates
Alphatec (ATEC) Q4 Earnings and Revenues Beat Estimates
Earnings Preview: Teleflex (TFX) Q4 Earnings Expected to Decline
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline
RxSight stock initiated with Market Perform rating by William Blair
RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?
Objectif de prix de l’action RxSight relevé à 11,50$ contre 11,00$ par Jefferies
RxSight stock price target raised to $11.50 from $11.00 at Jefferies